Akihiko Tanizawa

Obama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

A prospective study evaluating the safety and pharmacokinetics of ponatinib at a fixed dose in six paediatric patients with philadelphia chromosome-positive leukaemia: JCCG PedPona19 study.

A prospective study evaluating the safety and pharmacokinetics of ponatinib at a fixed dose in six paediatric patients with philadelphia chromosome-positive leukaemia: JCCG PedPona19 study.

Journal: British journal of haematology

Published: January 13, 2025

Favorable outcomes of de novo advanced phases of pediatric chronic myeloid leukemia in the tyrosine kinase inhibitor era.

Favorable outcomes of de novo advanced phases of pediatric chronic myeloid leukemia in the tyrosine kinase inhibitor era.

Journal: International journal of hematology

Published: December 15, 2024

Growth retardation and adult height in pediatric patients with chronic-phase chronic myeloid leukemia treated with tyrosine kinase inhibitors.

Growth retardation and adult height in pediatric patients with chronic-phase chronic myeloid leukemia treated with tyrosine kinase inhibitors.

Journal: Leukemia

Published: August 11, 2024

Does the Number of Turns during Sleep Have Utility in the Early Detection of Parkinson's Disease and Its Related Disorders?

Does the Number of Turns during Sleep Have Utility in the Early Detection of Parkinson's Disease and Its Related Disorders?

Journal: JMA journal

Published: December 07, 2023

Allogeneic stem cell transplantation for children and adolescents/young adults with de novo blastic phase chronic myeloid leukemia in the tyrosine kinase inhibitor era.

Allogeneic stem cell transplantation for children and adolescents/young adults with de novo blastic phase chronic myeloid leukemia in the tyrosine kinase inhibitor era.

Journal: American journal of hematology

Published: March 28, 2023

Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplant Diagnosed Using Ultrathin Bronchoscopy.

Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplant Diagnosed Using Ultrathin Bronchoscopy.

Journal: American journal of respiratory and critical care medicine

Published: April 29, 2022

Prognostic Factors for Outcomes of Allogeneic HSCT for Children and Adolescents/Young Adults With CML in the TKI Era.

Prognostic Factors for Outcomes of Allogeneic HSCT for Children and Adolescents/Young Adults With CML in the TKI Era.

Journal: Transplantation and cellular therapy

Published: February 01, 2022

Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia.

Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia.

Journal: Pediatric blood & cancer

Published: January 12, 2022

Functional analysis of a novel fusion protein PAX5-KIDINS220 identified in a pediatric Ph-like ALL patient.

Functional analysis of a novel fusion protein PAX5-KIDINS220 identified in a pediatric Ph-like ALL patient.

Journal: International journal of hematology

Published: May 19, 2020

Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: A retrospective nationwide study in Japan.

Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: A retrospective nationwide study in Japan.

Journal: Leukemia research

Published: August 26, 2018

Sequential use of second-generation tyrosine kinase inhibitors following imatinib therapy in pediatric chronic myeloid leukemia: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group.

Sequential use of second-generation tyrosine kinase inhibitors following imatinib therapy in pediatric chronic myeloid leukemia: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group.

Journal: Pediatric blood & cancer

Published: April 16, 2018

Long-term Results of the Risk-adapted Treatment for Childhood B-Cell Acute Lymphoblastic Leukemia: Report From the Japan Association of Childhood Leukemia Study ALL-97 Trial.

Long-term Results of the Risk-adapted Treatment for Childhood B-Cell Acute Lymphoblastic Leukemia: Report From the Japan Association of Childhood Leukemia Study ALL-97 Trial.

Journal: Journal of pediatric hematology/oncology

Published: February 08, 2017

Showing 1-12 of 30

Last Updated: 09/26/2026